Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 2
2008 2
2009 1
2011 2
2013 1
2017 3
2018 1
2019 2
2020 4
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia.
Kruse A, Abdel-Azim N, Kim HN, Ruan Y, Phan V, Ogana H, Wang W, Lee R, Gang EJ, Khazal S, Kim YM. Kruse A, et al. Among authors: gang ej. Int J Mol Sci. 2020 Feb 5;21(3):1054. doi: 10.3390/ijms21031054. Int J Mol Sci. 2020. PMID: 32033444 Free PMC article. Review.
CBP/Catenin antagonists: Targeting LSCs' Achilles heel.
Kim YM, Gang EJ, Kahn M. Kim YM, et al. Among authors: gang ej. Exp Hematol. 2017 Aug;52:1-11. doi: 10.1016/j.exphem.2017.04.010. Epub 2017 May 4. Exp Hematol. 2017. PMID: 28479420 Free PMC article. Review.
Targeting PI3K Signaling in Acute Lymphoblastic Leukemia.
Sanchez VE, Nichols C, Kim HN, Gang EJ, Kim YM. Sanchez VE, et al. Among authors: gang ej. Int J Mol Sci. 2019 Jan 18;20(2):412. doi: 10.3390/ijms20020412. Int J Mol Sci. 2019. PMID: 30669372 Free PMC article. Review.
Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia.
Gang EJ, Kim HN, Hsieh YT, Ruan Y, Ogana HA, Lee S, Pham J, Geng H, Park E, Klemm L, Willman CL, Carroll WL, Mittelman SD, Orgel E, Oberley MJ, Parekh C, Abdel-Azim H, Bhojwani D, Wayne AS, De Arcangelis A, Georges-Labouesse E, Wayner E, Bonig H, Minasyan A, Ten Hoeve J, Graeber TG, Müschen M, Heisterkamp N, Kim YM. Gang EJ, et al. Blood. 2020 Jul 9;136(2):210-223. doi: 10.1182/blood.2019001417. Blood. 2020. PMID: 32219444 Free PMC article.
Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia.
Park E, Gang EJ, Hsieh YT, Schaefer P, Chae S, Klemm L, Huantes S, Loh M, Conway EM, Kang ES, Hoe Koo H, Hofmann WK, Heisterkamp N, Pelus L, Keerthivasan G, Crispino J, Kahn M, Müschen M, Kim YM. Park E, et al. Among authors: gang ej. Blood. 2011 Aug 25;118(8):2191-9. doi: 10.1182/blood-2011-04-351239. Epub 2011 Jun 28. Blood. 2011. PMID: 21715311 Free PMC article.
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia.
Ruan Y, Kim HN, Ogana HA, Wan Z, Hurwitz S, Nichols C, Abdel-Azim N, Coba A, Seo S, Loh YE, Gang EJ, Abdel-Azim H, Hsieh CL, Lieber MR, Parekh C, Pal D, Bhojwani D, Durden DL, Kim YM. Ruan Y, et al. Among authors: gang ej. Front Oncol. 2021 Dec 1;11:766888. doi: 10.3389/fonc.2021.766888. eCollection 2021. Front Oncol. 2021. PMID: 34926269 Free PMC article.
23 results